Pharmaceutical Commerce - July/August 2012

Arkansas Best will build on Panther's time-definite and cold-chain services for life sciences

Latest Manhattan Research market study finds little growth in social media usage; also, the rise of the 'three screen' physician

Analysis of 'pharmacy related waste' finds $408 billion in potential annual savings

New sample reporting requirements will be a focus of this year's meeting

Despite the lack of headlines today as compared to late last year, the drug-shortage situation has not improved. FDA, congressional and industry actions are beginning to change the dynamic

Prospects for international policing of counterfeit drugs is dim

Modernized packaging technologies can change the drug-distribution dynamic - and improve overall healthcare

Cloud computing can be more than simply accessing databases and computing resources; it can be a pathway to business and research decisions

While 78% of survey respondents will "demand clear proof of cost savings" to ensure formulary placement, 44% of them have "little or no confidence" in the economic arguments presented by pharmacos

This year's IQPC meeting - its 10th anniversary - promises to be the biggest yet

The healthcare system is coming to grips with the wave of genomic diagnostics that has followed new biological therapy introductions

Dendreon's Provenge prostate-cancer treatment ramps up with unique supply chain complexities

In-depth statistical analysis using ZS Associates and IMS Health prescriber data demonstrates the value of rep-sourced communication

Dohmen pioneers an integrated, 'conflict free' pharmaceutical services company

With partial support from manufacturers themselves, home health services are emerging as a critical channel for specialties

A cloud-based network of marketing services providers will address the inefficiencies of current multichannel practices

Agency wins a 'campaign of the year' award from its client, Abbott Labs, for medical display